ClinicalTrials.govpublic full text
Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive
type 2 diabetes mellitus
ClinicalTrials.gov
Show glossary
Search for terms
Hide glossary
Study record managers: refer to the
Data Element Definitions
if submitting registration or results information.
Record · ID 67829 · SHA-256 e5bfa50054351e7a
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.